Navigation Links
MMP-2/MMP-9 Inhibitor IV [SB-3CT] from CHEMICON

ProductsMMP-2/MMP-9 Inhibitor IV [SB-3CT] from CHEMICON
Company CHEMICON
Item MMP-2/MMP-9 Inhibitor IV [SB-3CT]
Price $125.00
Description MMP-2 / MMP-9 Inhibitor IV is a potent, selective, slow binding and mechanism based inhibitor of human gelatinases. • Molecular weight: 306.4 • Molecular Formula: C(15)H(14)O(3)S(2). • The inhibitor is soluble in DMSO (100mg/mL).
Info CHEMICONCHEMICON
CHEMICON International, Inc.
28820 Single Oak Drive
Temecula, CA 92590
Customer Service: 800-437-7500
Tech Support: 800-437-7500
Fax Number: 800-437-7502
Web Site: http://www.chemicon.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. QIAGEN RNase Inhibitor (7500 U) from QIAGEN
2. RNase Inhibitor from Applied Biosystems
3. Recombinant RNasin® Ribonuclease Inhibitor from Promega
4. GeneChoice RNA Safe Recombinant Ribonuclease Inhibitor from GeneChoice, Inc.
5. RNaseOUT Recombinant Ribonuclease Inhibitor from Invitrogen
6. RNase Inhibitor (Cloned) from Ambion
7. gamma-Secretase Inhibitor IV, Unconjugated from Calbiochem
8. Plasminogen Activator Inhibitor (PAI-1) Colorimetric Assay Kit from AMERICAN DIAGNOSTICA
9. Rnase-free Ribonuclease Inhibitor from Chimerx
10. TypeOne Restriction Inhibitor from EPICENTRE Biotechnologies
11. PARP Inhibitor XI, DR2313 from Calbiochem
Feature Extraction Software; 1-year license for Commercial from Agilent Technologies
...tem from Molecular Devices provides precise dispen...he system handles a variety of plate formats for d...and is the first to handle 1536-well microplate wa...from four different channels to accommodate up to ...
Dithiothreitol from USB Corp.
...various commercial and lab-prepared glass arrays. ...ntent of the attached nucleic acid targets, and th...e optimal hybridization conditions for glass micro...to consider, it is impossible for one hybridizatio...
Biology Products:
(Date:11/4/2009)... Calif., Oct. 19 Spectros, develop...and imaging devices which shed light on life-threa...d exclusive distribution deals for both its T-Stat...ts covered include Australia, New Zealand, The Ne..., Italy, France, Spain, Portugal, Poland, Greece, ...
(Date:11/4/2009)... Oct. 20 Aware, Inc. (Na...hnology and biometrics software, today reported fi...mber 30, 2009. ,, Michael Tzannes, Aware,s Ch... today, we announced an agreement to sell our DSL ... fabless semiconductor company being spun out of I...
(Date:11/4/2009).... 26 BIO-key Internation...inger-based biometric identification software is s...the AABB TXPO conference being held at the New Orl...O-key will provide hands-on product demonstrations... in booth #424. Also, at 5 PM on Monday, October 2...
Breaking Biology News(10 mins):Spectros Signs New International Distribution Deals 2Aware, Inc. Reports Third Quarter 2009 Financial Results 2Aware, Inc. Reports Third Quarter 2009 Financial Results 3Aware, Inc. Reports Third Quarter 2009 Financial Results 4Aware, Inc. Reports Third Quarter 2009 Financial Results 5Aware, Inc. Reports Third Quarter 2009 Financial Results 6Aware, Inc. Reports Third Quarter 2009 Financial Results 7BIO-key(R) International Exhibiting at AABB TXPO 2In Health Care Today Its Electronic All the Way 58815 1In Health Care Today Its Electronic All the Way 58815 2In Health Care Today Its Electronic All the Way 58815 3Park Meadows Cosmetic Surgery a Leader in Breast Reconstruction Surgery Recognizes National Breast Cancer Awareness Month 58813 1Park Meadows Cosmetic Surgery a Leader in Breast Reconstruction Surgery Recognizes National Breast Cancer Awareness Month 58813 2Park Meadows Cosmetic Surgery a Leader in Breast Reconstruction Surgery Recognizes National Breast Cancer Awareness Month 58813 331 Breast Cancer Myths 26amp 3B Truths in 31 Days 58811 131 Breast Cancer Myths 26amp 3B Truths in 31 Days 58811 2
...release is available in French . Montreal, 13...ealth Centre (MUHC), McGill University and the Uni...medical use of cannabinoids do not cause an increa...ith an increase in some non-serious adverse events...rom the cannabis plant, or cannibinoids, are avail...
...towers Institute,s Rong Li Lab has discovered that...ammation may also have a role in the formation of ...ase (ADPKD) one of the most common life-threateni...ibiting the protein can slow the disease in mice. ...nline publication of Nature Medicine yesterday. ...
...ANCISCO, CA June 16, 2008 --- iZumi Bio, Inc. and... non-profit biomedical research organization, have...nsing agreement to focus on applications for induc... "reprogrammed" adult cells that have similar prop...tem (ES) cells, yet do not raise the same ethical ...
Other Biology News:Medicines derived from cannabis: a review of adverse events 2Rong Li Lab identifies new role of inflammatory protein in PKD and a possible treatment 2
(Date:11/5/2009)...OMAHA, Neb., Nov. 5 Tran...nounced financial results for the quarter ended Se...are presented in the tables that follow. ,, Th... loss of $366,000 or $0.01 per share for the third...,000 or $0.01 per share for the third quarter of 2...
(Date:11/5/2009)...FREMONT, Calif., Nov. 5 ...S), a leading developer of state-of-the-art geneti...er Sears, Ph.D. has joined the company,s Scientifi...designing and commercializing novel molecular diag...s, and on the development of computational biology...
(Date:11/5/2009)... Brooke Sanders brings a new lo... CA (PRWEB) November 5, 2009 -- Professional Repro...prographics company is pleased to present Brooke S... their graphics/PR specialist. The addition of Bro...tent growth within Professional Reprographics., , ...
(Date:11/4/2009)... ,, ROCKVILLE, Md., Nov. 4 Z...mpany focused on next-generation antibody drug dev...million in Series A funding from New Enterprise As... capital firms. The capital will be used to create...t address two or more biological targets with a si...
Breaking Biology Technology:Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 2WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 3WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 4Zyngenia, Inc. Raises $10 Million in Series A Funding 2Zyngenia, Inc. Raises $10 Million in Series A Funding 3Zyngenia, Inc. Raises $10 Million in Series A Funding 4